Literature DB >> 14871609

Insect population control using female specific pro-drug activation.

Maria Markaki1, Roger K Craig, Charalambos Savakis.   

Abstract

A system for population control of insects is proposed. It is based on transgenic insects expressing an enzyme which converts an inactive pro-drug into an active, toxic form. A model system is presented which relies on transposon-mediated integration of a bacterial cytosine deaminase (CD) gene into the genome of Drosophila melanogaster. We demonstrate female-specific sterility and transgene-dependent lethality when flies carrying the CD gene under a Drosophila female-specific promoter/enhancer are treated with 5-Fluorocytosine, a low-toxicity nucleoside analogue which is converted to toxic 5-Fluorouracil by the enzyme. The approach can be used with existing pro-insecticides and appropriate converting enzymes in combination with established mass rearing technology, for targeted, environmentally acceptable control of insects of economic and public health importance.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14871609     DOI: 10.1016/j.ibmb.2003.03.001

Source DB:  PubMed          Journal:  Insect Biochem Mol Biol        ISSN: 0965-1748            Impact factor:   4.714


  3 in total

1.  A mutant dec-1 transgene induces dominant female sterility in Drosophila melanogaster.

Authors:  Daniel K Spangenberg; Gail L Waring
Journal:  Genetics       Date:  2007-11       Impact factor: 4.562

2.  Multiplexed drug-based selection and counterselection genetic manipulations in Drosophila.

Authors:  Nick Matinyan; Mansi S Karkhanis; Yezabel Gonzalez; Antrix Jain; Alexander Saltzman; Anna Malovannaya; Alejandro Sarrion-Perdigones; Herman A Dierick; Koen J T Venken
Journal:  Cell Rep       Date:  2021-09-14       Impact factor: 9.423

3.  The natural insect peptide Neb-colloostatin induces ovarian atresia and apoptosis in the mealworm Tenebrio molitor.

Authors:  Elżbieta Czarniewska; Grzegorz Rosiński; Elżbieta Gabała; Mariola Kuczer
Journal:  BMC Dev Biol       Date:  2014-01-30       Impact factor: 1.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.